From Health Plan Week - After getting reassurance from CMS that no delay in implementation of the new International Classification of Diseases, 10th Edition (ICD-10) coding protocol would occur this year, health insurers were sideswiped not by the agency, but by the U.S. House of Representatives when on March 27 it passed unrelated legislation that includes a one-year delay of the revised code set. The Senate is expected to approve the bill on March 31. If the Senate vote goes as expected, this would mark the second such ICD-10 postponement in two years, with last year’s orchestrated by CMS. Read more
From Health Plan Week - Health insurers are on the defensive over the way some provider networks for public exchanges are designed, leading to criticism that consumers buying coverage on the new marketplaces don’t have access to out-of-network care. Read more
From Health Plan Week - FDA’s December 2013 approval of hepatitis C drug Sovaldi (sofosbuvir) has rattled health insurers, PBMs and state Medicaid programs, causing “near panic” with some plans because of the drug’s expense, its potential demographic reach and the timing of its market entry. Read more
Check out all of the benefits, sample issues & more!